Search





Search





Markets
/
Stocks
/
cvs
/

CVS Health Corp

CVS

Add to Watchlist

106.910USD

-1.170-1.08%

Close 07-23 16:00（ET）Quotes delayed by 15 min

135.88BMarket Cap

46.55P/E TTM

CVS Health Corp

106.910

-1.170-1.08%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-1.08%

5 Days

+0.38%

1 Month

+5.26%

6 Months

+28.79%

Year to Date

+34.72%

1 Year

+72.85%

Key Figures

107.360Open

107.550High

5.82MVolume

46.55P/E TTM

12.66P/E Dynamic

2.660Dividend TTM

0.46%Turnover Ratio

108.080Prev. Close

106.000Low

270.82MTurnover

29.45P/E Static

1.81P/B

2.49%Div Yield TTM

1.14%ROA

98.43052wk High

0.65Volume Ratio

4.61BNet Profit

1.27BShares

2.2965EPS TTM

0.62Beta

3.80%ROE

58.50052wk Low

1.43%Amplitude

15.56%Gross Margin

135.88BMarket Cap

3.94Reward/Risk

1.55%Risk Rate

TradingKey Stock Score of CVS Health Corp

Currency: USD Updated: 2026-07-23

Key Insights

CVS Health Corp's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 46 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 109.57.In the medium term, the stock price is expected to trend up.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CVS Health Corp's Score

Industry at a Glance

Industry Ranking

46 / 75

Overall Ranking

222 / 4547

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

35°C



Very Low

Very High

Neutral

CVS Health Corp Highlights

StrengthsRisks

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 402.07B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 73.28%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 73.28%.

Overvalued

The company’s latest PE is 46.54, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.15B shares, decreasing 2.66% quarter-over-quarter.

Held by Larry Robbins

Star Investor Larry Robbins holds 6.34M shares of this stock.

Analyst Rating

Based on 29 analysts

Buy

Current Rating

109.573

Target Price

-0.93%

Upside Space

CVS Health Corp News

Eli Lilly Zepbound Returns to CVS Formulary, Pre-Market Shares Rise as Much as 2%

TradingKey - Eli Lilly (LLY) shares rose nearly 2% in Thursday’s pre-market session as the market focused on a major decision from U.S. healthcare giant CVS Health (CVS). CVS announced it would restore insurance coverage for the weight-loss drug Zepbound and include Foundayo, an oral weight-loss medication newly approved in April, in its standard drug formulary.

TradingKeyThu, May 28

Telemedicine and Telehealth Stocks to Watch in 2026

TradingKey - The healthcare system was one of the first industries to go through a major transformation; now, investors are watching closely. Every day, we see new technology being created for diagnosing and treating diseases. The method of delivery in allowing patients access to care has changed al

TradingKeyMon, Feb 23

CVS Health 2.0: Leaner, Smarter, Stronger

TradingKey - In the midst of a chaotic healthcare environment of price scrutiny, margin pressure, and shifting consumer behavior, CVS Health (CVS) has undertaken a conscious shift: less bulk, more acuity.

TradingKeyMay 16, 2025